Single-cell analysis of CML patients bone marrow at diagnosis reveals coexistence of CD26-CD35+ healthy stem cells and CD26+CD35- CML stem cells, and how the ratio between these impacts TKI response.

Dividend announcements are not available. No other corporate actions details are available.

Financial Services Secretary M Nagaraju, who was also present at the ceremony, expressed his happiness with the bank's initiative.

The ASH Annual Meeting is one of the largest gatherings of the international hematology community, aggregating the latest scientific research on the pathogenesis and clinical treatment of hematologic ...

The global leukemia therapeutics treatment market has seen considerable growth, progressing from USD 14,504.8 million in 2022 to USD 15,246.7 million in 2023. With a projected compound annual growth ...

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for malignancies, today ...

95 percent of young innovative firms saw their revenues grow ... high-performance engines that use cutting-edge and competitive technology. Today, we offer a whole range of off-road and street ...